EZH2 Protein Expression Associates With the Early Pathogenesis, Tumor Progression and Prognosis of Non-small Cell Lung Carcinoma

PURPOSE: Enhancer of zeste homolog 2 (EZH2) promotes carcinogenesis by epigenetically silencing tumor suppressor genes. We studied EZH2 expression by immunohistochemistry in a large series of non-small cell lung carcinomas (NSCLC) in association with tumor characteristics and patient outcomes. EXPER...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Behrens, Carmen, Solis, Luisa M., Lin, Heather, Yuan, Ping, Tang, Ximing, Kadara, Humam, Riquelme, Erick, Galindo, Hector, Moran, Cesar A., Kalhor, Neda, Swisher, Stephen G., Simon, George R., Stewart, David J., Lee, J. Jack, Wistuba, Ignacio I.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890101/
https://ncbi.nlm.nih.gov/pubmed/24097870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3946
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items